Wnt5a-mediated autophagy promotes radiation resistance of nasopharyngeal carcinoma
- PMID: 35517407
- PMCID: PMC9066197
- DOI: 10.7150/jca.71526
Wnt5a-mediated autophagy promotes radiation resistance of nasopharyngeal carcinoma
Abstract
Wnt signaling pathways and autophagy play an essential role in tumor progression. Canonical Wnt signaling pathways in radiation resistance have been studied in the past, but it remains unclear whether the noncanonical Wnt signaling pathways can affect tumor radiation resistance through protective autophagy. Nasopharyngeal carcinoma, a particular subtype of head and neck squamous cell carcinoma, relies on radiation therapy. In this study, we found that radioactive rays could significantly promote the expression of Wnt noncanonical signaling pathways ligands in nasopharyngeal carcinoma, among which Wnt5A was the most markedly altered. We have demonstrated that Wnt5a can reduce the radiation sensitivity of nasopharyngeal carcinoma in vitro and in vitro experiments. Meanwhile, we found much more greater autophagosomes in overexpressed-Wnt5A nasopharyngeal carcinoma cells by electron microscopy. Further mechanism exploration revealed that Beclin1 is the main target of Wnt5A, and knocking down Beclin1 can partially reduce Wnt5a-induced radiation resistance. By studying Wnt5A-mediated protective autophagy in promoting radiation resistance in nasopharyngeal carcinoma cells, we hope that the Wnt5A and Beclin1 can become effective targets for overcoming radiation resistance in the future.
Keywords: Head and Neck Squamous Cell Carcinoma; Wnt5a; autophagy; nasopharyngeal carcinoma; radiation resistance.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures






Similar articles
-
Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.Anticancer Drugs. 2017 Feb;28(2):187-196. doi: 10.1097/CAD.0000000000000451. Anticancer Drugs. 2017. PMID: 27831944
-
WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.Oncotarget. 2015 Apr 30;6(12):10239-52. doi: 10.18632/oncotarget.3518. Oncotarget. 2015. PMID: 25823923 Free PMC article.
-
Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.J Oral Pathol Med. 2015 Nov;44(10):776-84. doi: 10.1111/jop.12292. Epub 2014 Dec 2. J Oral Pathol Med. 2015. PMID: 25459554
-
Multiple Roles of WNT5A in Breast Cancer.Med Sci Monit. 2016 Dec 22;22:5058-5067. doi: 10.12659/msm.902022. Med Sci Monit. 2016. PMID: 28005837 Free PMC article. Review.
-
Insight into the role of Wnt5a-induced signaling in normal and cancer cells.Int Rev Cell Mol Biol. 2015;314:117-48. doi: 10.1016/bs.ircmb.2014.10.003. Epub 2014 Nov 18. Int Rev Cell Mol Biol. 2015. PMID: 25619716 Review.
Cited by
-
The Multifaceted Role of Autophagy in Nasopharyngeal Carcinoma: Translational Perspectives on Pathogenesis, Biomarkers, Treatment Resistance, and Emerging Therapies.Cancers (Basel). 2025 Aug 5;17(15):2577. doi: 10.3390/cancers17152577. Cancers (Basel). 2025. PMID: 40805271 Free PMC article. Review.
-
Exosomes derived from cancer-associated fibrolasts mediated ciplatin resistance.Cytojournal. 2024 Dec 27;21:74. doi: 10.25259/Cytojournal_149_2024. eCollection 2024. Cytojournal. 2024. PMID: 39916998 Free PMC article.
-
m6A modification-dependent upregulation of WNT2 facilitates M2-like macrophage polarization and perpetuates malignant progression of nasopharyngeal carcinoma.Oncogene. 2025 Aug;44(31):2730-2745. doi: 10.1038/s41388-025-03452-7. Epub 2025 May 26. Oncogene. 2025. PMID: 40419792
-
Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential.Heliyon. 2024 Aug 12;10(16):e35989. doi: 10.1016/j.heliyon.2024.e35989. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253139 Free PMC article. Review.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68:394–424. - PubMed
-
- Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O. et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5:1749–1768. - PMC - PubMed
-
- Chow LQM. Head and Neck Cancer. N Engl J Med. 2020;382:60–72. - PubMed
-
- Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet (London, England) 2019;394:64–80. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous